Navigation Links
NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran

PHOENIX, Jan. 10 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB), nutrient research and technology, announced today that it has formed two joint ventures with HerbalScience Singapore Ltd Pte, a company that produces standardized botanical extracts for functional food and nutraceutical uses, and identifies novel chemistries for drug development through the application of its proprietary platform technology. The parties will establish two companies, one for nutraceutical products and functional food ingredient development from SRB and one for drug discovery from SRB.

Under the terms of the agreements, NutraCea will have an 80% interest in Rice Science, a newly formed limited liability company that will develop certain extracts targeted for specific health conditions. Rice Science has identified three specific areas of health that it will pursue: Diabetes, Arthritis and Immunity. The second newly formed company, Rice Rx, will be a limited liability company owned 50/50 by HerbalScience and NutraCea. It will advance drug discovery from SRB for licensing to life science and pharmaceutical companies.

Brad Edson, Chief Executive Officer of NutraCea commented, "Our ongoing clinical research continues to validate our beliefs regarding the inherent value of our proprietary products for various applications related to certain disease specific states such as joint health, immune response, diabetes, cardiovascular disease and more. We know that stabilized rice bran contains a rich bounty of natural compounds at therapeutic levels. We believe by isolating these specific elements, we can create quantifiable isolates that have the potential to be measurably effective in dealing with some of the most serious health threats that we face today. Additionally, many botanicals have been the basis for pharmaceutical drugs."

Robert Gow, Chairman and CEO of HerbalScience said, "We are pleased to partner with the world leader in stabilized rice bran technologies. Together with NutraCea, we feel we can develop proprietary and efficacious extracts from their stabilized rice bran that have clearly defined health and wellness benefits for use in foods and consumer products, and identify patentable chemistries that have the potential to be turned into drugs for the pharmaceutical industry."

About HerbalScience

HerbalScience is a privately-held life sciences company with offices in the United States and Singapore. HerbalScience is engaged in the discovery, development, manufacture, and marketing of proprietary botanical compounds for human health and wellness in the U.S. and international markets. The company has entered into development partnerships with major pharmaceutical and consumer products companies around the world. Utilizing its technology platform, HerbalScience develops highly effective botanical-based products that have been commercialized in North America, Europe and Asia. For more information, contact Dr. Robert Smith, Director of Market Development, at or visit HerbalScience at

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding (i) the successful future creation of quantifiable isolates that prove measurably effective in dealing with health threats, (ii) the development of proprietary and efficacious extracts from stabilized rice bran that have health and wellness benefits for use in foods and consumer products, and (iii) the identification of patentable chemistries that may be turned into drugs for the pharmaceutical industry, all of which statements are subject to market risks, and the possibility that NutraCea and its ventures with HerbalScience will not be able to identify, create, develop, or complete these items or to obtain sufficient customer demand for such items. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.

Company Contact:

Margie Adelman

Senior V.P. NutraCea


916-220-3500 cell

Investor Relations Contact:

Marilynn Meek

Financial Relations Board


Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NutraCea Announces Conference Call to Report Second Quarter Financial Results
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
4. Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i
5. Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan
6. DenteMax Forms Business Alliance With MEDILINQ
7. CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors
8. The Multiple Sclerosis Association of America Transforms Website with a New Look and New Technology
9. Premier Micronutrient Forms Strategic Partnership With EAR Inc.
10. Global Health Support Service Benchmark Study to Combat Growing Healthcare Costs and Prepare for Likely Health Care Reforms
11. In Progressive Move, 21st Services Forms Independent Medical Advisory Board to Study Longevity, Mortality Risk
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ... and regulatory/legal strategies all play a key ... says GBI Research . --> ... a key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: